AI Science Tracker
EN

Comparison of anomaly detection and supervised learning for acute myeloid leukemia blast identification: A proof-of-concept study

Affiliation not stated in the reviewed material · 29 Oct 2026 · medicine

Discovery

Comparison of anomaly detection and supervised learning for acute myeloid leukemia blast identification: A proof-of-concept study

Source check: Source checked. Not independent scientific confirmation.

Finding: This retrospective AML flow-cytometry study compares supervised, anomaly-detection and clustering approaches for blast identification and reports markedly different performance by prevalence, including two independent external validation samples. It qualifies narrowly as a clinical diagnostic-validation result.

Technology: Four anomaly detectors, Random Forest and UMAP-HDBSCAN are compared for blast identification using flow-cytometry features.

Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Four anomaly detectors, Random Forest and UMAP-HDBSCAN are compared for blast identification using flow-cytometry features.
Test and result
External check uses two independent samples only; results support a small proof-of-concept diagnostic comparison, not general clinical performance or clinical benefit.
Limitation / still unknown
External replication and real-world or clinical benefit were not established by the reviewed study; author affiliation is not stated in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://export.arxiv.org/api/query?id_list=2610.39447 · https://arxiv.org/pdf/2610.39447

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.